These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9706736)

  • 21. A systematic review of placebo-controlled trials of topiramate: How useful is a multiple-indications review for evaluating the adverse events of an antiepileptic drug?
    Donegan S; Dixon P; Hemming K; Tudur-Smith C; Marson A
    Epilepsia; 2015 Dec; 56(12):1910-20. PubMed ID: 26662191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacology of topiramate versus lamotrigine versus phenobarbital: comparison of efficacy and side effects using odds ratios.
    Lathers CM; Schraeder PL; Claycamp HG
    J Clin Pharmacol; 2003 May; 43(5):491-503. PubMed ID: 12751270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topiramate: a new antiepileptic drug.
    Privitera MD
    Ann Pharmacother; 1997 Oct; 31(10):1164-73. PubMed ID: 9337443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The use of topiramate in the treatment of focal epilepsy in children].
    Kremenchugskaia MR; Globa OV; Kuzenkova LM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):33-8. PubMed ID: 24430032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.
    Schreiner A; Stollhoff K; Ossig W; Unkelbach S; Lüer W; Bogdanow M; Schauble B;
    Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypohidrosis related to the administration of topiramate to children.
    Arcas J; Ferrer T; Roche MC; Martínez-Bermejo A; López-Martín V
    Epilepsia; 2001 Oct; 42(10):1363-5. PubMed ID: 11737174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary observations on topiramate in pediatric epilepsies.
    Glauser TA
    Epilepsia; 1997; 38 Suppl 1():S37-41. PubMed ID: 9092958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topiramate monotherapy in epilepsy and migraine prevention.
    Silberstein SD; Ben-Menachem E; Shank RP; Wiegand F
    Clin Ther; 2005 Feb; 27(2):154-65. PubMed ID: 15811478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topiramate: its pharmacological properties and therapeutic efficacy in epilepsy.
    Latini G; Verrotti A; Manco R; Scardapane A; Del Vecchio A; Chiarelli F
    Mini Rev Med Chem; 2008 Jan; 8(1):10-23. PubMed ID: 18220981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term treatment retention with topiramate.
    Deckers CL; Renier WO
    Epilepsia; 2001 Feb; 42(2):290-1. PubMed ID: 11240609
    [No Abstract]   [Full Text] [Related]  

  • 31. Interaction of topiramate with carbamazepine: two case reports and a review of clinical experience.
    Mack CJ; Kuc S; Mulcrone SA; Pilley A; Grünewald RA
    Seizure; 2002 Oct; 11(7):464-7. PubMed ID: 12237076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topiramate as a new antiepileptic drug in epileptic children in Iran.
    Fallah R
    Indian J Pediatr; 2006 Dec; 73(12):1073-5. PubMed ID: 17202632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current data on topiramate].
    Herranz JL
    Rev Neurol; 2000 Jun; 30 Suppl 1():S132-6. PubMed ID: 10904980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticonvulsant efficacy of topiramate in phenytoin-resistant kindled rats.
    Reissmüller E; Ebert U; Löscher W
    Epilepsia; 2000 Apr; 41(4):372-9. PubMed ID: 10756400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cognitive impairments due to add-on therapy with topiramate].
    Huppertz HJ; Quiske A; Schulze-Bonhage A
    Nervenarzt; 2001 Apr; 72(4):275-80. PubMed ID: 11320862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-Year Retention Rates of Levetiracetam, Topiramate, and Oxcarbazepine: A Retrospective Hospital-Based Study.
    Sunwoo JS; Park BS; Ahn SJ; Hwang S; Park CY; Jun JS; Kim DW; Lee ST; Jung KH; Park KI; Chu K; Jung KY; Lee SK
    Clin Neuropharmacol; 2017; 40(2):56-62. PubMed ID: 28118167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Topiramate: a broad spectrum antiepileptic administered to 224 patients with refractory epilepsies].
    Herranz JL
    Rev Neurol; 2000 Nov 1-15; 31(9):822-8. PubMed ID: 11127082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of adjunctive topiramate on cognitive function in patients with epilepsy.
    Lee S; Sziklas V; Andermann F; Farnham S; Risse G; Gustafson M; Gates J; Penovich P; Al-Asmi A; Dubeau F; Jones-Gotman M
    Epilepsia; 2003 Mar; 44(3):339-47. PubMed ID: 12614389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring efficacy and tolerability outcomes in patients with difficult-to-treat epilepsy receiving adjunctive topiramate at different titration rates--an exploratory study.
    Kurth C; Schäuble B; Schreiner A; Rettig K; Steinhoff BJ
    Acta Neurol Scand; 2009 Aug; 120(2):80-7. PubMed ID: 19432934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topiramate and psychiatric adverse events in patients with epilepsy.
    Mula M; Trimble MR; Lhatoo SD; Sander JW
    Epilepsia; 2003 May; 44(5):659-63. PubMed ID: 12752464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.